Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection

WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...

Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico

Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved...

Symptom Burden Prevalent in Childhood Cancer Survivors

Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater...

High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology

There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA...

Thrombectomy Linked to Better Outcomes for Acute Stroke, Large Infarct

For patients with acute stroke and a large infarct, thrombectomy plus medical care results in better functional outcomes and lower mortality, according...

Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation

For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR) naltrexone,...

More Data Suggests 'Ultraprocessed' Foods Can Shorten Your Life

People who eat large amounts of ultra-processed foods have a slightly higher risk of premature death than those who mostly shun the industrially produced...

Neuropathy Nerve Damage Often Goes Undiagnosed

THURSDAY, May 9, 2024 — Though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of...

Eating Disorders Common in People With Type 1 Diabetes

One in every four people age 16 or older with type 1 diabetes may be struggling with an eating disorder, a new review of data on the subject finds. Type...

There's a New Set of COVID Variants Called FLiRT: What You Need to Know

The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...

Bayer to Unveil Late-Breaking Data from Phase III OASIS 1 and 2 for Elinzanetant in the Treatment of Vasomotor Symptoms Associated with Menopause

Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound...

Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effective

Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more...

Read more news...

Recently Added

Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
  • Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
  • Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development